Ken Colley

MycoMedica Life Sciences is a pioneering biopharmaceutical company whose mission is to revolutionize the development of a new class of safe and efficacious psychedelic medications for mental health and neurodegenerative disorders. We believe that every individual deserves access to quality healthcare and are committed to ensuring that no one is left behind in their pursuit of whole human health.